Management of hemolytic uremic syndrome - Wikidata - awgldk - TriplyDB

Management of hemolytic uremic syndrome

Management of hemolytic uremic syndrome

http://www.wikidata.org/entity/Q57161996

about

Infection-related hemolysis and susceptibility to Gram-negative bacterial co-infection Hemolytic uremic syndrome in adults: A case report Atypical Haemolytic Uraemic Syndrome Associated with Clostridium difficile Infection Successfully Treated with Eculizumab.

P2860

Q26801651-E8793203-CDE2-4CD9-9310-8857F4ABAE97 Q33442019-A7260B62-C3F5-47C5-B4A2-8767D81113B3 Q55079383-3016A7FA-689C-4051-A2FA-F539DD8B6192

P2860

Management of hemolytic uremic syndrome

http://www.wikidata.org/entity/Q57161996

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2014

@uk

name

Management of hemolytic uremic syndrome

@en

Management of hemolytic uremic syndrome

@nl

type

label

Management of hemolytic uremic syndrome

@en

Management of hemolytic uremic syndrome

@nl

prefLabel

Management of hemolytic uremic syndrome

@en

Management of hemolytic uremic syndrome

@nl

P1433

Q57161996-E34FAE6D-3729-46A3-994A-6DCDFE6EF63F

P1476

Q57161996-E670AFC2-1E54-4D03-8E69-EA7CAAF48151

P2093

Q57161996-262496E0-0A5B-41BD-875D-611C5D2D60B2

Q57161996-A231D3FA-59F0-4969-A6A9-51FC8963CADA

Q57161996-A28A5AF7-4583-4C7B-BA01-1C828C104692

P2860

Q57161996-0130C5B9-9DC4-411C-83EB-C2ADA5512A84

Q57161996-072A894A-3DCC-47C8-AF09-DB7F097E7B35

Q57161996-09703C21-34B2-4B29-8614-41BB7E25E813

Q57161996-0A0EC56D-7784-4062-A6D7-2D2E0A05EA21

Q57161996-0BAA9B64-C786-4503-B759-8643D743C3A0

Q57161996-0D6E0B69-69ED-4139-9F32-9E8E44D920B1

Q57161996-102BBF92-4217-4D08-AC8B-0AD196B459AD

Q57161996-10A7EAD8-79A2-471F-8430-D602D5B7F95D

Q57161996-13BAABE6-C353-46A9-9962-049EE8B1006D

Q57161996-13D54A3D-7A0E-408F-A4C2-AECB30CFF948

P304

Q57161996-402559AD-522B-4F27-8651-B40EF47DFAD5

P31

Q57161996-E28807AE-E9C4-49F4-B0D0-D06352CFF723

P356

Q57161996-F2C7C1B3-C761-4C1C-80BC-0F57EDA790EE

P407

Q57161996-222BC0F4-C72A-4788-88BE-A6DA7DE726F4

P478

Q57161996-D8727D36-810C-42D2-8E78-DDF9E46BA640

P577

Q57161996-8E415EEB-A271-4CC2-A2E6-430166202A5A

P698

Q57161996-29221E26-5F7F-4776-98D7-DAB802BFD094

P932

Q57161996-59F79FD4-5405-49BF-B076-05709BB92456

P356

P1433

F1000prime reports

P1476

Management of hemolytic uremic syndrome

@en

P2093

David Kavanagh

http://www.w3.org/2001/XMLSchema#string

Neil S Sheerin

http://www.w3.org/2001/XMLSchema#string

Shreya Raman

http://www.w3.org/2001/XMLSchema#string

P2860

Atypical hemolytic uremic syndrome

Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome

Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response

Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome.

P304

119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12703/P6-119

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25580273

http://www.w3.org/2001/XMLSchema#string

P932

4278190

http://www.w3.org/2001/XMLSchema#string